This may be due to the increased methylation of Adrb2 (Adrenoceptor beta 2) mRNA caused by the deletion of FTO, which leads to a decrease in its mRNA and protein levels and is involved in the development of depression via the Adrb2-c-MYC-sirt1 pathway. Here, ADRB2 is linked to depressive disorder.